selected works

Working in private organizations limits what I can show publicly, but here are some publically available things that I can show.

publications

  • DeWitt M , Wierzba TF. Automatic Case Cluster Detection Using Hospital Electronic Health Record Data. Biology Methods and Protocols. Published online March 15, 2023:bpad004. doi:10.1093/biomethods/bpad004

  • DeWitt ME, Tjaden AH, Herrington D, et al. COVID-19 Symptoms by Variant Period in the North Carolina COVID-19 Community Research Partnership, North Carolina, USA - Volume 29, Number 1—January 2023 - Emerging Infectious Diseases journal - CDC. doi:10.3201/eid2901.221111

  • Stone, T. J., DeWitt, M., Johnson, J. W., Beardsley, J. R., Munawar, I., Palavecino, E., Luther, V. P., Ohl, C. A., & Williamson, J. C. (2023). Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed? Antimicrobial Stewardship & Healthcare Epidemiology, 3(1), e47. https://doi.org/10.1017/ash.2022.363

  • Polk, C., Sampson, M., Fairman, R. T., DeWitt, M. E., Leonard, M., Neelakanta, A., Davidson, L., Roshdy, D., Branner, C., McCurdy, L., Ludden, T., Tapp, H., & Passaretti, C. (2023). Evaluation of a health system’s implementation of a monkeypox care model under the RE-AIM framework. Therapeutic Advances in Infectious Disease, 10, 20499361231158464. https://doi.org/10.1177/20499361231158463

  • DeWitt, M. E., Herrington, D. M., & Sanders, J. W. (2023). Venous or Arterial Thrombosis in COVID-19 Cases in the North Carolina COVID-19 Community Research Partnership (NC-CCRP). Research and Practice in Thrombosis and Haemostasis, 100080. https://doi.org/10.1016/j.rpth.2023.100080

  • Semelka, C. T., DeWitt, M. E., Blevins, M. W., Holbrook, B. C., Sanders, J. W., & Alexander-Miller, M. A. (2023). Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults. Immunity & Ageing, 20(1), 4. https://doi.org/10.1186/s12979-023-00327-x

  • DeWitt ME, Polk C, Williamson J, Shetty AK, Passaretti CL, McNeil CJ, et al. Global monkeypox case hospitalisation rates: A rapid systematic review and meta-analysis. EClinicalMedicine 2022;54:101710. https://doi.org/10.1016/j.eclinm.2022.101710.

  • Sampson MM, Polk CM, Fairman RT, DeWitt ME, Leonard MK, Davidson L, et al. Monkeypox testing delays: The need for drastic expansion of education and testing for monkeypox virus. Infect Control Hosp Epidemiol 2022:1–2. https://doi.org/10.1017/ice.2022.237.

  • C. T. Semelka, M. E. DeWitt, K. E. Callahan, D. M. Herrington, M. A. Alexander-Miller, J. O. Yukich, I. Munawar, L. H. McCurdy, M. A. Gibbs, W. S. Weintraub and J. W. Sanders. “Frailty and COVID-19 mRNA Vaccine Antibody Response in The COVID-19 Community Research Partnership.” J Gerontol A Biol Sci Med Sci; DOI: https://doi.org/10.1093/gerona/glac095

  • Michael E. DeWitt, Christopher Scheib, Morgan Jones and Pamela Cowin North Carolina Medical Journal July 2021, 82 (4) 284-286; DOI: https://doi.org/10.18043/ncm.82.4.284

  • Summers, Phillip, and Michael DeWitt. “Analysis of the Winston-Salem Public Transit System.” Virginia Policy Review, October 31, 2018. http://www.virginiapolicyreview.org/1/post/2018/10/analysis-of-the-winston-salem-public-transit-system.html.

software

Sam Abbott, Joel Hellewell, Katharine Sherratt, Katelyn Gostic, Joe Hickson, Hamada S. Badr, Michael DeWitt, Robin Thompson, EpiForecasts, and Sebastian Funk (2020). EpiNow2: Estimate Real-Time Case Counts and Time-Varying Epidemiological Parameters, DOI: 10.5281/zenodo.3957489

Sam Abbott, Nikos Bosse, Joel Hellewell, Katharine Sherratt, James Munday, Robin Thompson, Aurelien Chateigner, Sylvain Mareschal, Andrea Rau, Nathalie Vialaneix, Michael DeWitt and Sebastian Funk (2020). EpiSoon: Forecast Cases Using Reproduction Numbers. R package version 0.3.0.

DeWitt et al., (2019). tidyqwi: A Tidy Approach to Accessing The US Census Bureau’s Quarterly Workforce Indicators. Journal of Open Source Software, 4(38), 1462, https://doi.org/10.21105/joss.01462

Bruno Castanho Silva and Michael DeWitt (2019). SCtools: Extensions for Synthetic Controls Analysis. R package version 0.3.0. https://CRAN.R-project.org/package=SCtools

Working Papers

DeWitt ME, Sampson MM, Fairman RT, McNeil CJ, Polk CM, Passaretti CL, et al. Estimated Monkeypox Susceptible MSM Population in North Carolina 2022:2022.07.21.22277860. https://doi.org/10.1101/2022.07.21.22277860.

DeWitt, Michael E. “Rapid Impact Analysis of B 1.1.7 Variant on the Spread of SARS-CoV-2 in North Carolina.” MedRxiv, February 9, 2021, 2021.02.07.21251291. https://doi.org/10.1101/2021.02.07.21251291.

DeWitt, Michael E. “Automatic Contact Tracing for Outbreak Detection Using Hospital Electronic Medical Record Data.” MedRxiv, September 13, 2020, 2020.09.08.20190876. https://doi.org/10.1101/2020.09.08.20190876.

technical papers

public comment

This section represents any public analysis that has been presented to any public bodies.

applications

This sections represents public facing applications.

presentations

This is a non-exhaustive list of presentations that I have given.

  • Designing a Student Retention Model, North Carolina Independent Colleges and Universities Institutional Research Directors Meeting, December 2018

  • Does My Instructor Look Like Me: A Multi-Institution Look at Implicit Bias in Grading, Southern Association for Institutional Research, October 2018

  • Comparing Two Groups: Effect Sizes, Wake Forest University Business Analytics Team, September 2018

  • Comparing Two Groups: T-Test, Wake Forest University Business Analytics Team, August 2018

  • Introduction to R, Wake Forest University Professional Development, March 2018

  • Overview of Distributions, Wake Forest University Business Analytics Team, February 2018

  • Measures of Central Tendency, Wake Forest University Business Analytics Team, December 2017

  • Graphing Different Kinds of Data, Wake Forest University Business Analytics Team, November 2017

patents

Procede d’identifier, gerer et réincorporer les produits complexes comme les produits valorises(WO2019154657 - 2019-08-15, applied)

Systeme d’identifier, gerer et reincorporer les produits complexes comme les produits valorises(WO2019154656 - 2019-08-15, applied)